| abstract |
The invention relates to the use of factor Xa inhibitors, in particular of oxazolidinones of formula (I), for the treatment and/or prophylaxis of sepsis, disseminated intravascular coagulation, septic shocks, septic organ dysfunction, septic organ failure and/or ARD and use thereof for production of a medicament for the treatment and/or prophylaxis of sepsis, disseminated intravascular coagulation, septic shocks, septic organ dysfunction, septic organ failure and/or ARD. |